Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

bluebird bio Says Continuing To Work Expeditiously To Complete Delayed Filings

Author: Benzinga Newsdesk | May 29, 2024 07:09am

On March 26, 2024, bluebird announced that it will restate its consolidated financial statements for the first three quarters and full-year 2022, as well as the first three quarters of 2023. As a result, the Company's Annual Report Form 10-K for 2023 and its Q1 2024 Form 10-Q have been delayed.

Consistent with previous updates, the restatement is not expected to impact the Company's cash position or revenue. Sterling will transition to oversee the restatement process upon his start date.

Posted In: BLUE